Cancer-Associated Thrombosis in Cirrhotic Patients with Hepatocellular Carcinoma
It is common knowledge that cancer patients are more prone to develop venous thromboembolic complications (VTE). It is therefore not surprising that patients with hepatocellular carcinoma (HCC) present with a significant risk of VTE, with the portal vein being the most frequent site (PVT). However,...
Main Authors: | Alberto Zanetto, Elena Campello, Luca Spiezia, Patrizia Burra, Paolo Simioni, Francesco Paolo Russo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-11-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/10/11/450 |
Similar Items
-
Potential Association between Distal Deep Vein Thrombosis and Asymptomatic Atherosclerosis
by: Angelo Adamo, et al.
Published: (2021-10-01) -
HEPATOSPLENIC SCHISTOSOMIASIS-ASSOCIATED CHRONIC PORTAL VEIN THROMBOSIS: RISK FACTOR FOR HEPATOCELLULAR CARCINOMA?
by: George Felipe Bezerra Darce, et al.
Published: (2023-09-01) -
Presence of Hepatocellular Carcinoma Does Not Affect Course and Response to Anticoagulation of Bland Portal Vein Thrombosis in Cirrhotic Patients
by: Benevento F, et al.
Published: (2023-03-01) -
Mesenteric Ischemia: A Case of Extrapulmonary Presentation in COVID-19
by: Radhika Salpekar, et al.
Published: (2023-01-01) -
Superficial Venous Thrombosis: A Comprehensive Review
by: Marco Mangiafico, et al.
Published: (2024-02-01)